MedTrace Logo

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00314158 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 523

Last updated 2016-11-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Conditions

Interventions

DRUG

Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension

One drop twice daily in each study eye for six months

DRUG

Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension

One drop twice daily in each study eye for six months

DRUG

Timolol 5 mg/ml eye drops, solution

One drop twice daily in each study eye for six months

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-01-31
Completion
2007-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00314158 on ClinicalTrials.gov